Published in J Geriatr Psychiatry Neurol on March 25, 2009
Genetic influences on cognitive decline in Parkinson's disease. Mov Disord (2012) 1.10
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol (2014) 1.07
A large study reveals no association between APOE and Parkinson's disease. Neurobiol Dis (2012) 1.05
Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. J Neurol Neurosurg Psychiatry (2010) 0.98
HDL and cognition in neurodegenerative disorders. Neurobiol Dis (2014) 0.84
Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis. Parkinsons Dis (2012) 0.83
Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis Treat (2015) 0.83
Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease. Mov Disord (2013) 0.82
The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease. Front Psychiatry (2016) 0.81
Transcriptomics of maternal and fetal membranes can discriminate between gestational-age matched preterm neonates with and without cognitive impairment diagnosed at 18-24 months. PLoS One (2015) 0.78
Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status. Parkinsonism Relat Disord (2014) 0.77
Cognitive decline in Parkinson disease. Nat Rev Neurol (2017) 0.77
Emerging preclinical pharmacological targets for Parkinson's disease. Oncotarget (2016) 0.75
Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease. Biomed Res Int (2013) 0.75
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Alzheimer's disease. Lancet (2011) 5.35
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ (2011) 4.37
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord (2007) 3.48
Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord (2006) 2.96
A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord (2008) 2.81
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord (2006) 2.47
Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology (2007) 2.32
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord (2014) 2.30
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord (2011) 2.27
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry (2004) 2.21
Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol (2013) 2.19
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol (2009) 2.10
Endovascular acute stroke treatment performed by vascular interventional radiologists: is it safe and efficacious? Cardiovasc Intervent Radiol (2012) 2.06
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord (2006) 2.04
Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord (2012) 1.99
Good outcome in every fourth resuscitation attempt is achievable--an Utstein template report from the Stavanger region. Resuscitation (2011) 1.89
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 1.88
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol (2012) 1.86
Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Parkinsonism Relat Disord (2013) 1.74
Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord (2008) 1.71
A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol (2010) 1.70
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.66
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord (2007) 1.55
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2010) 1.55
Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord (2009) 1.54
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry (2009) 1.54
Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology (2005) 1.53
Epidemiology of psychosis in Parkinson's disease. J Neurol Sci (2009) 1.51
Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord (2003) 1.51
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2010) 1.50
Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study. Epilepsia (2011) 1.50
Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord (2007) 1.48
Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry (2008) 1.47
The rate of cognitive decline in Parkinson disease. Arch Neurol (2004) 1.44
Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death. J Neurosci (2014) 1.43
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39
Epidemiology of Parkinson's disease. J Neurol (2008) 1.38
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33
Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord (2008) 1.33
Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc Natl Acad Sci U S A (2009) 1.32
Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiol Aging (2012) 1.31
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord (2010) 1.31
Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry (2010) 1.28
The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. J Clin Psychiatry (2010) 1.25
Assessment and treatment of pain in people with dementia. Nat Rev Neurol (2012) 1.22
Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. Neuropsychology (2011) 1.22
Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One (2012) 1.21
Is there an increase of postpartum hemorrhage, and is severe hemorrhage associated with more frequent use of obstetric interventions? Acta Obstet Gynecol Scand (2010) 1.21
Who suffers most? Dementia and pain in nursing home patients: a cross-sectional study. J Am Med Dir Assoc (2008) 1.20
Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol (2005) 1.19
Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. J Neurol Neurosurg Psychiatry (2007) 1.17
Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry (2011) 1.17
The psychosocial burden on spouses of the elderly with stroke, dementia and Parkinson's disease. Int J Geriatr Psychiatry (2002) 1.15
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord (2010) 1.09
Frequency and correlates of caregiver-reported sleep disturbances in a sample of persons with early dementia. J Am Geriatr Soc (2010) 1.09
Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int J Geriatr Psychiatry (2006) 1.08
Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord (2008) 1.08
Quality of chest compressions during 10min of single-rescuer basic life support with different compression: ventilation ratios in a manikin model. Resuscitation (2008) 1.08
Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia. Int J Geriatr Psychiatry (2013) 1.07
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis (2006) 1.06
Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Mov Disord (2006) 1.06
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease. J Neurol (2012) 1.05
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord (2005) 1.05
The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation. J Cell Sci (2010) 1.05
A novel blood test for the early detection of Alzheimer's disease. J Alzheimers Dis (2011) 1.04
Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts. J Alzheimers Dis (2011) 1.02
Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J Alzheimers Dis (2013) 1.01
Gray matter correlations of cognition in incident Parkinson's disease. Mov Disord (2010) 1.01
Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry (2004) 1.01
Cognitive impairment in nondemented Parkinson's disease. Mov Disord (2011) 1.01
Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord (2010) 0.99